|
Patient
|
Sex
|
Age (years)
|
Diagnosis
|
Weight (kg)
|
APACHE II
|
The cause of AKI
|
The value of Cre on admission to ICU (mg/dl)
|
Duration of CHDF (days)
|
|---|
|
1
|
Male
|
75
|
Ruptured AAA
|
70.7
|
31
|
Hemorrhagic shock
|
1.32
|
66
|
|
2
|
Male
|
59
|
OHCA
|
88.9
|
42
|
PCAS
|
0.98
|
5
|
|
3
|
Male
|
46
|
Congenital heart disease
|
50.0
|
21
|
Major cardiac operation
|
0.69
|
45
|
|
4
|
Male
|
58
|
ML
|
58.3
|
41
|
Drug induced
|
2.04
|
38
|
|
Mean ± SE
| |
59.5 ± 6.0
|
-
|
70.0 ± 8.5
|
33.8 ± 4.9
|
-
|
1.25 + 0.29
|
38.5 + 12.7
|
|
BUN (mmol/l)
|
24 h CL
cre
(ml/min)
|
Q
D
(l/h)
|
Q
F
(l/h)
|
Predictive CL
total
(l/h)
|
Calculated optimal dose of LVFX (mg)
|
|
42
|
3.4
|
1.0
|
2.0
|
4.0
|
200
|
|
43
|
0.9
|
1.0
|
2.0
|
4.0
|
200
|
|
40
|
-
|
1.0
|
2.0
|
-
|
-
|
|
32
|
3.4
|
0.5
|
1.5
|
2.9
|
145
|
|
39.3 ± 5.0
|
2.6 ± 0.8
|
0.86 + 0.13
|
1.88 + 0.13
|
3.6 ± 0.4
|
182 + 18.3
|
- AAA abdominal aortic aneurysm, OHCA out-of-hospital cardiac arrest, ML malignant lymphoma, APACHE II Acute Physiology and Chronic Health Evaluation II score, AKI acute kidney injury, PCAS post-cardiac arrest syndrome, Cre creatinine, ICU intensive care unit, CHDF continuous hemodiafiltration, BUN blood urea nitrogen, CLcre creatinine clearance, CLtotal total clearance, QD dialysate flow, QF ultrafiltrate flow, LVFX levofloxacin, SE standard error.
